LifeMD vs MEDVi
LifeMD costs $100 less a month, and both sell semaglutide.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
LifeMD
Best for: bloodwork inside the monthly price rather than billed on top
Visit LifeMD →
If you are choosing between LifeMD and MEDVi, the first difference is cost: LifeMD is $100 a month cheaper at the entry price. Both prescribe semaglutide, so moving from one to the other would not change your drug. LifeMD leads our six-part score, 7.9 to 7.1. One of the two has an FDA warning letter on record, covered below.
LifeMD vs MEDVi price
LifeMD is the cheaper way in: $149 a month against $249 a month at MEDVi. That is $100 less each month (40% lower), or about $1,200 over a year of treatment.
Drug by drug: Semaglutide is cheaper at LifeMD ($149 a month vs $249 a month).
Medications and formats
Both sell semaglutide; only LifeMD lists tirzepatide.
On format, LifeMD prices brand-name pens, while MEDVi prices compounded injections.
If you want the FDA-approved brand rather than a compounded version, LifeMD is the only one of the two with a brand-name price.
Where each one treats patients
LifeMD lists 50 states, and MEDVi lists 48 states.
They overlap in 48 states. LifeMD alone covers Mississippi and North Dakota.
Pricing
LifeMD
First month $75, then $149/mo. Brand medication billed separately, or $0-$25/mo copay with commercial insurance.
Medication only; plus the $149/mo program fee.
Medication only (starting); plus the program fee. As low as $0-$25/mo with insurance.
Medication only; plus the $149/mo program fee.
MEDVi
Refills are locked in at $299. The first month is $179 in the 'SUMMER Sale,' and some MEDVi landing pages offer the first month at $149.
Flat 'Starting at $249' — no intro discount shown.
$99 Membership + Medication Cost — medication cost not published (varies/insurance may reimburse). 'Availability is subject to change.'
$99 Membership + Medication Cost — medication cost not published. COMPOUNDED tirzepatide ($349 in our current entry) is no longer published anywhere on glp1.medvi.org, home.medvi.org, or the intake flow (0 mentions) — treat as discontinued/not published, do not carry the $349 row forward.
What each price covers
Both prices cover the clinician visit and coaching.
LifeMD's price also covers lab work, which MEDVi does not claim.
MEDVi's price also covers the medication itself and shipping, which LifeMD does not claim.
LifeMD is silent on shipping.
MEDVi is silent on lab work.
That matters most for the drug: unless LifeMD confirms otherwise, budget for medication on top of its listed price.
LifeMD
Covered by the monthly price
Medication
Charged on top
Clinician visits
In the price
Shipping
Not stated
Lab work
In the price
Coaching
In the price
MEDVi
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
In the price
Where each one scores higher
Overall, LifeMD scores 7.9 and MEDVi 7.1 out of 10.
LifeMD is stronger on value (10.0 vs 2.8).
MEDVi is stronger on user experience (8.0 vs 3.0) and support (8.5 vs 5.5).
Effectiveness, trust & safety and accessibility are within half a point.
LifeMD
7.9/10
MEDVi
7.1/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
The FDA sent MEDVi a warning letter dated February 20, 2026 (letter 721455), and it is still open.
LifeMD has no FDA warning letter on record with us.
Features & Coverage
| Feature | LifeMD | MEDVi |
|---|---|---|
| Starting Price | ✓$149/mo | $249/mo |
| Features | 0 features | ✓7 features |
| States Available | ✓50 | 48 |
| Compounded | — | ✓ Yes |
| Brand Name | ✓ Yes | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | ✓None | 1 letter |
About LifeMD
LifeMD is a publicly traded telehealth seller. It carries brand-name GLP-1 medications only.
Read our full LifeMD review →About MEDVi
Two clinical groups do the treating at MEDVi: CareGLP Affiliated P.C.s, plus clinicians from OpenLoop Health. Its weight-loss menu holds compounded GLP-1s, injections and tablets alike, the molecule being semaglutide, next to Zepbound and Wegovy under their brand names. Licensed US pharmacies fill all of it.
Read our full MEDVi review →Pros & Cons
LifeMD
What we like
- Semaglutide costs $149 a month, 85% below the $990 median for brand-name semaglutide across the sellers we compare
- Tirzepatide costs $349 a month, 72% below the $1249 median for brand-name tirzepatide across the sellers we compare
- The monthly price includes clinician visits, lab work and coaching
- Serves all 50 states
- We found no FDA warning letters issued to LifeMD
Watch-outs
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Not included in the monthly price: medication
- Ask which pharmacy fills the prescription before you pay, so you can check its license
MEDVi
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication, clinician visits, shipping and coaching
- Serves 48 states
- Names 3 pharmacies that fill its prescriptions, which most sellers do not
Watch-outs
- Semaglutide costs $249 a month, 35% above the $184 median for compounded semaglutide across the sellers we compare
- The FDA has issued MEDVi a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
LifeMD wins this one, 7.9 to 7.1, above all for bloodwork inside the monthly price rather than billed on top. It also costs $100 less each month than MEDVi. MEDVi fits better if knowing which pharmacy fills the vial: it names Triad Rx is your priority.
Choose LifeMD if…
You want bloodwork inside the monthly price rather than billed on top and an opening price near $149 a month.
Choose MEDVi if…
You want knowing which pharmacy fills the vial: it names Triad Rx and an opening price near $249 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Found
Tirzepatide at $169/month, 37% below the typical price
From $149/mo
Get started →Breeze Meds
Knowing which pharmacy fills the vial: it names Belmar Pharmacy
From $199/mo
Get started →HealthRX
Compounded semaglutide at $133/month
From $133/mo
Get started →LifeMD vs MEDVi: FAQ
Close alternatives to LifeMD and MEDVi
- LifeMD vs altRX
- LifeMD vs Gala
- LifeMD vs Sprout Health
- LifeMD vs Aquivia Health
- MEDVi vs Cabana
- MEDVi vs Next Vial
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.